Related references
Note: Only part of the references are listed.Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
Sabela Bobillo et al.
HAEMATOLOGICA (2021)
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study
Vincent Camus et al.
HAEMATOLOGICA (2021)
Harmonizing Cell-Free DNA Collection and Processing Practices through Evidence-Based Guidance
Sarah R. Greytak et al.
CLINICAL CANCER RESEARCH (2020)
Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction
Jee-Soo Lee et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA
Davide Rossi et al.
HEMATOLOGICAL ONCOLOGY (2020)
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI
Amy S. Ruppert et al.
BLOOD (2020)
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial
Heiko Schoder et al.
BLOOD (2020)
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
George W. Wright et al.
CANCER CELL (2020)
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
Christopher K. Rushton et al.
BLOOD ADVANCES (2020)
Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study
Marie-Helene Delfau-Larue et al.
BLOOD ADVANCES (2020)
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network
Daniela Drandi et al.
HEMASPHERE (2020)
Circulating tumor DNA assessment in patients with diffuse large B-cell lymphoma following CAR T-cell therapy
Nasheed M. Hossain et al.
LEUKEMIA & LYMPHOMA (2019)
Clonal haematopoiesis: a source of biological noise in cell-free DNA analyses
C. Abbosh et al.
ANNALS OF ONCOLOGY (2019)
Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas
Anne-Katrin Hickmann et al.
BMC CANCER (2019)
Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction
David M. Kurtz et al.
CELL (2019)
Exploring the Potential of Shallow Whole-Genome Sequencing for Diagnosis and Disease Monitoring of Lymphoma in Liquid Biopsy
Lennart Raman et al.
BLOOD (2019)
Biological background of the genomic variations of cf-DNA in healthy individuals
J. Liu et al.
ANNALS OF ONCOLOGY (2019)
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Christian Grommes et al.
BLOOD (2019)
MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma
Laura S. Hiemcke-Jiwa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Detectable Circulating Tumor DNA 28 Days after the CD19 CAR T-Cell Therapy, Axicabtagene Ciloleucel, Is Associated with Poor Outcomes in Patients with Diffuse Large B-Cell Lymphoma
Matthew J. Frank et al.
BLOOD (2019)
Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma (MCL)
Mitchell Smith et al.
BLOOD (2019)
Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA
David M. Kurtz et al.
BLOOD (2019)
Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory Follicular Lymphoma
Franck Morschhauser et al.
BLOOD (2019)
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
Rishu Agarwal et al.
NATURE MEDICINE (2019)
Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma
Brian C-H Chiu et al.
BLOOD ADVANCES (2019)
The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid
Laura S. Hiemcke-Jiwa et al.
HEMATOLOGICAL ONCOLOGY (2018)
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
Valeria Spina et al.
BLOOD (2018)
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
Katherine A. Hoadley et al.
CELL (2018)
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
Yuebi Hu et al.
CLINICAL CANCER RESEARCH (2018)
Liquid biopsy for the identification of intravascular large B-cell lymphoma
Yasuhito Suehara et al.
HAEMATOLOGICA (2018)
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
Christopher Melani et al.
HAEMATOLOGICA (2018)
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
Shamzah Araf et al.
LEUKEMIA (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Jae H. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Liquid biopsy for the identification of intravascular large B-cell lymphoma
Yasuhito Suehara et al.
HAEMATOLOGICA (2018)
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making
Christopher Melani et al.
HAEMATOLOGICA (2018)
Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction
Laura S. Hiemcke-Jiwa et al.
JAMA OPHTHALMOLOGY (2018)
Extending Circulating Tumor DNA Analysis to Ultralow Abundance Mutations: Techniques and Challenges
Andrew E. Rodda et al.
ACS SENSORS (2018)
Circulating tumor DNA to predict timing of relapse in mantle cell lymphoma.
Mark J. Roschewski et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
David M. Kurtz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort
Elodie Bohers et al.
BLOOD CANCER JOURNAL (2018)
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shu Yi Shen et al.
NATURE (2018)
Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
Joshua Moss et al.
NATURE COMMUNICATIONS (2018)
Circulating Tumor DNA Dynamics during Therapy Predict Outcomes in Mantle Cell Lymphoma
Rahul Lakhotia et al.
BLOOD (2018)
Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma
Marie-Helene Delfau-Larue et al.
BLOOD ADVANCES (2018)
Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies
Andi K. Cani et al.
ONCOTARGET (2017)
Minimal Residual Disease Assessment in Lymphoma: Methods and Applications
Alex F. Herrera et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma
Clementine Sarkozy et al.
ONCOTARGET (2017)
Non-invasive detection of somatic mutations using nextgeneration sequencing in primary central nervous system lymphoma
Maxime Fontanilles et al.
ONCOTARGET (2017)
Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals
Ligang Xia et al.
SCIENTIFIC REPORTS (2017)
5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages
Chun-Xiao Song et al.
CELL RESEARCH (2017)
Diffuse large B-cell lymphoma genotyping on the liquid biopsy
Davide Rossi et al.
BLOOD (2017)
Transformation of marginal zone lymphoma (and association with other lymphomas)
Carla Casulo et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy et al.
BLOOD (2016)
Core needle biopsies and surgical excision biopsies in the diagnosis of lymphoma-experience at the Lymph Node Registry Kiel
Alice Johl et al.
ANNALS OF HEMATOLOGY (2016)
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
Sarit E. Assouline et al.
BLOOD (2016)
Postibrutinib outcomes in patients with mantle cell lymphoma
Peter Martin et al.
BLOOD (2016)
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
Bruce D. Cheson et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β
Yoshito Nakanishi et al.
CANCER RESEARCH (2016)
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Matthew W. Snyder et al.
CELL (2016)
Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes
Qing Kang et al.
CLINICAL BIOCHEMISTRY (2016)
Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
Vincent Camus et al.
HAEMATOLOGICA (2016)
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies
Michel Meignan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma
Vincent Camus et al.
LEUKEMIA & LYMPHOMA (2016)
Integrated digital error suppression for improved detection of circulating tumor DNA
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2016)
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
Florian Scherer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Hodgkin lymphoma: Pathology and biology
Stephan Mathas et al.
SEMINARS IN HEMATOLOGY (2016)
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study
Robert Kridel et al.
PLOS MEDICINE (2016)
Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
Vincent Camus et al.
HAEMATOLOGICA (2016)
Retrospective Analysis of 56 Cases of Transformed Waldenstrom Macroglobulinemia. a Study on Behalf of the French Innovative Leukemia Organization (FILO)
Eric Durot et al.
BLOOD (2016)
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
David M. Kurtz et al.
BLOOD (2015)
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach
Yasuhiro Oki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis
Hugo J. A. Adams et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Digital PCR analysis of circulating nucleic acids
Irena Hudecova
CLINICAL BIOCHEMISTRY (2015)
Next-generation surveillance strategies for patients with lymphoma
Jonathon B. Cohen et al.
FUTURE ONCOLOGY (2015)
Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis
Elodie Bohers et al.
HAEMATOLOGICA (2015)
Cost-Effectiveness Analysis of Routine Surveillance Imaging of Patients With Diffuse Large B-Cell Lymphoma in First Remission
Scott F. Huntington et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
Mark Roschewski et al.
LANCET ONCOLOGY (2015)
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson et al.
NATURE MEDICINE (2015)
Toward understanding and exploiting tumor heterogeneity
Ash A. Alizadeh et al.
NATURE MEDICINE (2015)
Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis
Elodie Bohers et al.
HAEMATOLOGICA (2015)
Frameless image-guided stereotactic brain biopsies: emphasis on diagnostic yield
Sodaba Khatab et al.
ACTA NEUROCHIRURGICA (2014)
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes
Nyasha Chambwe et al.
BLOOD (2014)
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma
Salim Kanoun et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma
Myriam Sasanelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Utility of Routine Post-Therapy Surveillance Imaging in Diffuse Large B-Cell Lymphoma
Carrie A. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
M. Ladetto et al.
LEUKEMIA (2014)
Pharmacological and genomic profiling identifies NF-kappa B-targeted treatment strategies for mantle cell lymphoma
Rami Rahal et al.
NATURE MEDICINE (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Genetics of Follicular Lymphoma Transformation
Laura Pasqualucci et al.
CELL REPORTS (2014)
Utility of Flow Cytometry of Cerebrospinal Fluid as a Screening Tool in the Diagnosis of Central Nervous System Lymphoma
Meredith Pittman et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma
Philippe Armand et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer
L-Y Huw et al.
ONCOGENESIS (2013)
Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
Malek Faham et al.
BLOOD (2012)
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Jens G. Lohr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma
Neta Goldschmidt et al.
ANNALS OF HEMATOLOGY (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Analysis of the coding genome of diffuse large B-cell lymphoma
Laura Pasqualucci et al.
NATURE GENETICS (2011)
Detection and quantification of rare mutations with massively parallel sequencing
Isaac Kinde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study
Christiane Pott et al.
BLOOD (2010)
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases
Anna Maria Di Giacomo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
Abdulwahab J. Al-Tourah et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Georg Lenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting
Maurilio Ponzoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets.: Report of the BIOMED-2 Concerted Action BHM4-CT98-3936
P. A. S. Evans et al.
LEUKEMIA (2007)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma
PA Hamlin et al.
BLOOD (2003)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
